Skip to content
PubMed This is a summary of 14 peer-reviewed journal articles Updated
Medical Genetics

Decoding Your Diagnosis: Subtypes, Genetics, and Lab Reports

At a Glance

Primary hyperoxaluria has three genetic subtypes—PH1, PH2, and PH3. Doctors interpret genetic variants together with urine metabolites, 24-hour oxalate, blood oxalate, and kidney function to confirm the diagnosis and plan monitoring.

Understanding your laboratory and genetic reports is a vital step in managing Primary Hyperoxaluria (PH). Because PH is not a single disease but a group of three distinct genetic conditions, your “subtype” determines your monitoring plan and future treatment options [1][2].

The Three Subtypes of PH

Each subtype is caused by a different “broken” enzyme in the liver. While they all lead to high oxalate, they differ in their genetic cause and typical outcomes. Keep in mind that individual severity and treatment response can vary greatly; this table does not strictly predict your own disease course.

Subtype Gene Affected Missing Enzyme Key Urinary Marker General Severity
PH1 AGXT AGT Glycolate Often the most severe; high risk of kidney failure if untreated [3][2].
PH2 GRHPR GRHPR Glycerate Can lead to significant kidney disease and stones; median age for kidney failure is around 43 [4][1].
PH3 HOGA1 HOGA1 HOG or DHG Often diagnosed youngest; high stone risk but lower risk of total kidney failure [5][6].

Decoding Your Genetic Report

A genetic report for PH is more than just a “positive” or “negative” result. To confirm a diagnosis, doctors usually look for biallelic variants [7]. This means there must typically be two mutations found—one inherited from each parent—because PH is an autosomal recessive condition [8].

  • Pathogenic/Likely Pathogenic: These terms mean the mutation is known (or very likely) to cause the disease [9].
  • VUS (Variant of Uncertain Significance): This is a “maybe.” It means a change was found, but scientists aren’t sure yet if it actually causes the disease [9]. A VUS alone should not be used to establish or exclude a PH diagnosis without further testing [8].
  • Zygosity: You may see the word Homozygous (two copies of the same mutation) or Compound Heterozygous (two different mutations in the same gene) [7][10]. Both can cause PH.

Note: Sometimes a genetic test only finds one variant, which may reflect testing limitations rather than rule out PH. A genetics expert can help interpret these results alongside your biochemistry.

Interpreting Your Lab Results

Your lab reports will list several chemicals. Understanding what these “metabolites” signify can help you track how the disease is affecting the body.

  • 24-Hour Urinary Oxalate: This remains an important tool for measuring how much oxalate the kidneys are excreting [4]. A single “spot” urine test can miss the diagnosis in nearly 10% of cases [4].
  • Plasma Oxalate: If the kidneys are damaged and can’t filter well (reduced eGFR), oxalate builds up in the blood [11]. In these cases, blood (plasma) levels become increasingly important to track [12].
  • Glycolate, Glycerate, and HOG/DHG: These are “clues” that point to your specific subtype.
    • High glycolate points to PH1 [6].
    • High glycerate points to PH2 [6].
    • HOG (4-hydroxy-2-oxoglutarate) and DHG (2,4-dihydroxyglutarate) point to PH3 [6].
    • Note: HOG is very unstable and can disappear if the urine isn’t handled perfectly; DHG is often a more reliable marker for PH3 [6].

Completeness Checklist (Discussion Aid)

When you review your records, you can use this checklist as an aid to ensure you have a complete picture.

  1. Genetic Confirmation:
    • [ ] Does the report test all three genes (AGXT, GRHPR, HOGA1)? [2]
    • [ ] Are two mutations (variants) identified, or has a genetics team reviewed the results? [7]
    • [ ] Is the classification (Pathogenic vs. VUS) clear? [9]
  2. Laboratory Baseline:
    • [ ] At least two separate 24-hour urine collections (since oxalate levels can vary by over 30% day-to-day) [4].
    • [ ] Creatinine levels included in the urine test (to assess if the collection was adequate) [13].
    • [ ] Subtype Metabolites (glycolate, glycerate, or HOG/DHG) were measured [6].
  3. Kidney Function:
    • [ ] A recent eGFR (estimated Glomerular Filtration Rate) to check overall kidney health [14].
    • [ ] Plasma Oxalate levels, especially if eGFR is declining [11].

Common questions in this guide

What are the three types of primary hyperoxaluria?
Primary hyperoxaluria includes PH1, PH2, and PH3. PH1 is linked to AGXT and high glycolate, PH2 to GRHPR and high glycerate, and PH3 to HOGA1 and HOG or DHG. The types have different typical kidney risks, but individual disease severity can vary.
What does it mean when a genetic report shows biallelic variants?
Biallelic means that two variants were found in the same disease-related gene, usually one inherited from each parent. The variants may be identical or may be two different variants in that gene. A genetics professional can determine whether the variants are disease-causing and fit the other test results.
Can a VUS confirm or rule out primary hyperoxaluria?
A VUS is a genetic change whose role in disease is not yet known. A VUS alone should not be used to confirm or exclude primary hyperoxaluria. Clinicians interpret it with urine and blood testing, family information, and other available evidence.
Which laboratory tests help distinguish PH1, PH2, and PH3?
A 24-hour urine oxalate test measures oxalate excretion, while glycolate, glycerate, HOG, and DHG can provide clues to the subtype. Plasma oxalate becomes especially useful when kidney filtration is reduced. Doctors interpret these results together with genetic testing and kidney function measurements.
Can a normal urine marker rule out a primary hyperoxaluria subtype?
Not necessarily. A normal glycolate or glycerate result does not automatically rule out the corresponding subtype, so it should be interpreted with genetic testing and the rest of the biochemical evaluation. HOG is unstable, which means sample handling can affect PH3 marker results; DHG may be more reliable.
Why might my doctor repeat a 24-hour urine oxalate test?
Urine oxalate can vary substantially from day to day, so one collection may not show a dependable baseline. Two separate 24-hour collections can provide a clearer picture, and urine creatinine helps assess whether each collection was complete. A spot urine test may miss some cases.
What can a high plasma oxalate level mean in primary hyperoxaluria?
When kidney filtration declines, the kidneys cannot remove oxalate as effectively, so oxalate can build up in the blood. Plasma oxalate is therefore increasingly important to monitor when eGFR is reduced. The meaning of an individual result and its relationship to systemic oxalosis should be reviewed with a kidney specialist.

Questions For You

Answer a question to get research tailored to you. Your answers are private.

Get notified when new evidence is published on Primary hyperoxaluria.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Does the genetic report show biallelic variants, and have we confirmed that these are 'in trans' (meaning one from each parent)?
  2. 2.Given the subtype found, what is the typical risk of progressing to chronic kidney disease (CKD) based on current guidelines?
  3. 3.If the urinary glycolate or glycerate levels were normal, does that completely rule out those specific subtypes, or should we still rely on the genetic results?
  4. 4.Since 24-hour urine oxalate can vary day-to-day, should we repeat the test to get a more accurate baseline?
  5. 5.Is the current plasma oxalate level high enough to indicate a risk of systemic oxalosis?

References

References (14)
  1. 1

    Liver peroxisomal alanine:glyoxylate aminotransferase and the effects of mutations associated with Primary Hyperoxaluria Type I: An overview.

    Oppici E, Montioli R, Cellini B

    Biochimica et biophysica acta 2015; (1854(9)):1212-9.

    PMID: 25620715
  2. 2

    Clinical practice recommendations for primary hyperoxaluria: an expert consensus statement from ERKNet and OxalEurope.

    Groothoff JW, Metry E, Deesker L, et al.

    Nature reviews. Nephrology 2023; (19(3)):194-211 doi:10.1038/s41581-022-00661-1.

    PMID: 36604599
  3. 3

    Primary hyperoxaluria type 1: time for prime time?

    Bacchetta J, Wood KD

    Clinical kidney journal 2022; (15(Suppl 1)):i1-i3 doi:10.1093/ckj/sfab233.

    PMID: 35592621
  4. 4

    Patients with primary hyperoxaluria type 2 have significant morbidity and require careful follow-up.

    Garrelfs SF, Rumsby G, Peters-Sengers H, et al.

    Kidney international 2019; (96(6)):1389-1399 doi:10.1016/j.kint.2019.08.018.

    PMID: 31685312
  5. 5

    Primary hyperoxaluria type 3: from infancy to adulthood in a genetically unique cohort.

    Julius M, Lavsky HS, Kalfon L, et al.

    Pediatric nephrology (Berlin, Germany) 2025; (40(3)):731-741 doi:10.1007/s00467-024-06536-w.

    PMID: 39476025
  6. 6

    Simultaneous analysis of urinary metabolites for preliminary identification of primary hyperoxaluria.

    Clifford-Mobley O, Hewitt L, Rumsby G

    Annals of clinical biochemistry 2016; (53(Pt 4)):485-94 doi:10.1177/0004563215606158.

    PMID: 26342005
  7. 7

    Primary hyperoxaluria type 1 in children: clinical and laboratory manifestations and outcome.

    Wannous H

    Pediatric nephrology (Berlin, Germany) 2023; (38(8)):2643-2648 doi:10.1007/s00467-023-05917-x.

    PMID: 36917293
  8. 8

    Global genetic prevalence estimates of primary hyperoxaluria are greater than previously reported.

    Mandrile G, Rumsby G, Sciannameo V, et al.

    Clinical kidney journal 2025; (18(7)):sfaf194 doi:10.1093/ckj/sfaf194.

    PMID: 40873808
  9. 9

    Functional analysis of amino acid substitutions within human AGT1 in a cell-based platform to support the diagnosis of primary hyperoxaluria type 1.

    Gatticchi L, Bellezza I, Rumsby G, et al.

    The Journal of biological chemistry 2025; (301(8)):110494 doi:10.1016/j.jbc.2025.110494.

    PMID: 40683450
  10. 10

    Genetic Diagnosis of Hyperoxaluria Type 3 Patients Using Haplotype Analysis.

    Ataabadi ST, Behi L, Mojbafan M, Hooman N

    Kidney & blood pressure research 2025; (50(1)):189-197 doi:10.1159/000544093.

    PMID: 39933499
  11. 11

    Primary and secondary hyperoxaluria: Understanding the enigma.

    Bhasin B, Ürekli HM, Atta MG

    World journal of nephrology 2015; (4(2)):235-44 doi:10.5527/wjn.v4.i2.235.

    PMID: 25949937
  12. 12

    End Points for Clinical Trials in Primary Hyperoxaluria.

    Milliner DS, McGregor TL, Thompson A, et al.

    Clinical journal of the American Society of Nephrology : CJASN 2020; (15(7)):1056-1065 doi:10.2215/CJN.13821119.

    PMID: 32165440
  13. 13

    Rapid liquid chromatography tandem mass-spectrometry screening method for urinary metabolites of primary hyperoxaluria.

    Woodward G, Pryke R, Hoppe B, Rumsby G

    Annals of clinical biochemistry 2019; (56(2)):232-239 doi:10.1177/0004563218811365.

    PMID: 30373392
  14. 14

    Genetic assessment in primary hyperoxaluria: why it matters.

    Mandrile G, Beck B, Acquaviva C, et al.

    Pediatric nephrology (Berlin, Germany) 2023; (38(3)):625-634 doi:10.1007/s00467-022-05613-2.

    PMID: 35695965

This page is for informational purposes only and does not constitute medical advice. It explains primary hyperoxaluria genetic and laboratory reports; discuss your results with your genetics team or kidney specialist.